| Year |
Citation |
Score |
| 2023 |
Chen YC, Shishikura S, Moseson DE, Ignatovich AJ, Lomeo J, Zhu A, Horava SD, Richard CA, Park K, Yeo Y. Control of drug release kinetics from hot-melt extruded drug-loaded polycaprolactone matrices. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 37295729 DOI: 10.1016/j.jconrel.2023.05.049 |
0.483 |
|
| 2022 |
Pei Y, Wang J, Khaliq NU, Meng F, Oucherif KA, Xue J, Horava SD, Cox AL, Richard CA, Swinney MR, Park K, Yeo Y. Development of poly(lactide-co-glycolide) microparticles for sustained delivery of meloxicam. Journal of Controlled Release : Official Journal of the Controlled Release Society. 353: 823-831. PMID 36521690 DOI: 10.1016/j.jconrel.2022.12.019 |
0.498 |
|
| 2022 |
Kim W, Ly NK, He Y, Li Y, Yuan Z, Yeo Y. Protein corona: Friend or foe? Co-opting serum proteins for nanoparticle delivery. Advanced Drug Delivery Reviews. 192: 114635. PMID 36503885 DOI: 10.1016/j.addr.2022.114635 |
0.305 |
|
| 2022 |
Chen YC, Moseson DE, Richard CA, Swinney MR, Horava SD, Oucherif KA, Cox AL, Hawkins ED, Li Y, DeNeve DF, Lomeo J, Zhu A, Lyle LT, Munson EJ, Taylor LS, ... ... Yeo Y, et al. Development of hot-melt extruded drug/polymer matrices for sustained delivery of meloxicam. Journal of Controlled Release : Official Journal of the Controlled Release Society. 342: 189-200. PMID 34990702 DOI: 10.1016/j.jconrel.2021.12.038 |
0.474 |
|
| 2020 |
Elnaggar MG, Jiang K, Eldesouky HE, Pei Y, Park J, Yuk SA, Meng F, Dieterly AM, Mohammad HT, Hegazy YA, Tawfeek HM, Abdel-Rahman AA, Aboutaleb AE, Seleem MN, Yeo Y. Antibacterial nanotruffles for treatment of intracellular bacterial infection. Biomaterials. 262: 120344. PMID 32905902 DOI: 10.1016/J.Biomaterials.2020.120344 |
0.389 |
|
| 2020 |
Kim H, Lee HS, Jeon Y, Park W, Zhang Y, Kim B, Jang H, Xu B, Yeo Y, Kim DR, Lee CH. Bioresorbable, Miniaturized Porous Silicon Needles on Flexible Water-Soluble Backing for Unobtrusive, Sustained Delivery of Chemotherapy. Acs Nano. PMID 32401016 DOI: 10.1021/Acsnano.0C02343 |
0.381 |
|
| 2020 |
Jun Y, Xu J, Kim H, Park JE, Jeong YS, Min JS, Yoon N, Choi JY, Yoo J, Bae SK, Chung SJ, Yeo Y, Lee W. Carfilzomib delivery by quinic acid-conjugated nanoparticles: Discrepancy between tumoral drug accumulation and anticancer efficacy in a murine 4T1 orthotopic breast cancer model. Journal of Pharmaceutical Sciences. PMID 31945310 DOI: 10.1016/J.Xphs.2020.01.008 |
0.447 |
|
| 2019 |
Taha MS, Cresswell GM, Park J, Lee W, Ratliff TL, Yeo Y. Sustained delivery of carfilzomib by tannic acid-based nanocapsules helps develop antitumor immunity. Nano Letters. PMID 31657935 DOI: 10.1021/Acs.Nanolett.9B04147 |
0.359 |
|
| 2019 |
Wang J, Meng F, Kim BK, Ke X, Yeo Y. In-vitro and in-vivo difference in gene delivery by lithocholic acid-polyethyleneimine conjugate. Biomaterials. 217: 119296. PMID 31254934 DOI: 10.1016/J.Biomaterials.2019.119296 |
0.355 |
|
| 2019 |
Tamam H, Park J, Gadalla HH, Masters AR, Abdel-Aleem JA, Abdelrahman SI, Abdelrahman AA, Lyle LT, Yeo Y. Development of liposomal gemcitabine with high drug loading capacity. Molecular Pharmaceutics. PMID 31136710 DOI: 10.1021/Acs.Molpharmaceut.8B01284 |
0.406 |
|
| 2019 |
Park JE, Park J, Jun Y, Oh Y, Ryoo G, Jeong YS, Gadalla HH, Min JS, Jo JH, Song MG, Kang KW, Bae SK, Yeo Y, Lee W. Expanding therapeutic utility of carfilzomib for breast cancer therapy by novel albumin-coated nanocrystal formulation. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 30954620 DOI: 10.1016/J.Jconrel.2019.04.006 |
0.305 |
|
| 2019 |
Park J, Park J, Castanares MA, Collins DS, Yeo Y. Magnetophoretic delivery of a tumor priming agent for chemotherapy of metastatic murine breast cancer. Molecular Pharmaceutics. PMID 30916974 DOI: 10.1021/Acs.Molpharmaceut.8B01148 |
0.37 |
|
| 2019 |
Pang L, Pei Y, Uzunalli G, Hyun H, Lyle LT, Yeo Y. Surface Modification of Polymeric Nanoparticles with M2pep Peptide for Drug Delivery to Tumor-Associated Macrophages. Pharmaceutical Research. 36: 65. PMID 30859335 DOI: 10.1007/S11095-019-2596-5 |
0.446 |
|
| 2019 |
Meng F, Wang J, Ping Q, Yeo Y. Camouflaging Nanoparticles for Ratiometric Delivery of Therapeutic Combinations. Nano Letters. PMID 30707035 DOI: 10.1021/Acs.Nanolett.8B04017 |
0.536 |
|
| 2018 |
Xu J, Lee SS, Seo H, Pang L, Jun Y, Zhang RY, Zhang ZY, Kim P, Lee W, Kron SJ, Yeo Y. Quinic Acid-Conjugated Nanoparticles Enhance Drug Delivery to Solid Tumors via Interactions with Endothelial Selectins. Small (Weinheim An Der Bergstrasse, Germany). e1803601. PMID 30411856 DOI: 10.1002/Smll.201803601 |
0.487 |
|
| 2018 |
Hyun H, Park J, Willis K, Park JE, Lyle LT, Lee W, Yeo Y. Surface modification of polymer nanoparticles with native albumin for enhancing drug delivery to solid tumors. Biomaterials. 180: 206-224. PMID 30048910 DOI: 10.1016/J.Biomaterials.2018.07.024 |
0.479 |
|
| 2018 |
Meng F, Wang J, Ping Q, Yeo Y. Quantitative Assessment of Nanoparticle Biodistribution by Fluorescence Imaging, Revisited. Acs Nano. PMID 29920064 DOI: 10.1021/Acsnano.8B02881 |
0.385 |
|
| 2018 |
Yuk SA, Sanchez-Rodriguez DA, Tsifansky MD, Yeo Y. Recent advances in nanomedicine for sepsis treatment. Therapeutic Delivery. 9: 435-450. PMID 29722636 DOI: 10.4155/Tde-2018-0009 |
0.355 |
|
| 2018 |
Park J, Park JE, Hedrick VE, Wood KV, Bonham C, Lee W, Yeo Y. A Comparative In Vivo Study of Albumin-Coated Paclitaxel Nanocrystals and Abraxane. Small (Weinheim An Der Bergstrasse, Germany). e1703670. PMID 29570231 DOI: 10.1002/Smll.201703670 |
0.446 |
|
| 2018 |
Gad SF, Park J, Park JE, Fetih GN, Tous SS, Lee W, Yeo Y. Enhancing docetaxel delivery to multidrug-resistant cancer cells with albumin-coated nanocrystals. Molecular Pharmaceutics. PMID 29341617 DOI: 10.1021/Acs.Molpharmaceut.7B00783 |
0.403 |
|
| 2017 |
Appelbe OK, Kim BK, Rymut N, Wang J, Kron SJ, Yeo Y. Radiation-enhanced delivery of plasmid DNA to tumors utilizing a novel PEI polyplex. Cancer Gene Therapy. PMID 29255216 DOI: 10.1038/S41417-017-0004-Z |
0.376 |
|
| 2017 |
Park J, Pei Y, Hyun H, Castanares MA, Collins DS, Yeo Y. Small molecule delivery to solid tumors with chitosan-coated PLGA particles: A lesson learned from comparative imaging. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 29111150 DOI: 10.1016/J.Jconrel.2017.10.037 |
0.468 |
|
| 2017 |
Liu Y, Tamam H, Yeo Y. Mixed Liposome Approach for Ratiometric and Sequential Delivery of Paclitaxel and Gemcitabine. Aaps Pharmscitech. PMID 28971370 DOI: 10.1208/S12249-017-0877-Z |
0.425 |
|
| 2017 |
Pei Y, Mohamed MF, Seleem MN, Yeo Y. Particle engineering for intracellular delivery of vancomycin to methicillin-resistant Staphylococcus aureus (MRSA)-infected macrophages. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 28797580 DOI: 10.1016/J.Jconrel.2017.08.007 |
0.398 |
|
| 2017 |
Han N, Xu J, Pang L, Hyun H, Park J, Yeo Y. Development of surface-variable polymeric nanoparticles for drug delivery to tumors. Molecular Pharmaceutics. PMID 28368124 DOI: 10.1021/Acs.Molpharmaceut.7B00050 |
0.431 |
|
| 2016 |
Abouelmagd SA, Meng F, Kim BK, Hyun H, Yeo Y. Tannic acid-mediated surface functionalization of polymeric nanoparticles. Acs Biomaterials Science & Engineering. 2: 2294-2303. PMID 28944286 DOI: 10.1021/Acsbiomaterials.6B00497 |
0.391 |
|
| 2016 |
Park J, Sun B, Yeo Y. Albumin-coated nanocrystals for carrier-free delivery of paclitaxel. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 28049022 DOI: 10.1016/J.Jconrel.2016.12.040 |
0.477 |
|
| 2016 |
Meng F, Han N, Yeo Y. Organic nanoparticle systems for spatiotemporal control of multimodal chemotherapy. Expert Opinion On Drug Delivery. PMID 27476442 DOI: 10.1080/17425247.2016.1218464 |
0.503 |
|
| 2016 |
Park J, Kadasala NR, Abouelmagd SA, Castanares MA, Collins DS, Wei A, Yeo Y. Polymer-iron oxide composite nanoparticles for EPR-independent drug delivery. Biomaterials. 101: 285-295. PMID 27310916 DOI: 10.1016/J.Biomaterials.2016.06.007 |
0.485 |
|
| 2016 |
Sun B, Taha MS, Ramsey B, Torregrosa-Allen S, Elzey BD, Yeo Y. Intraperitoneal chemotherapy of ovarian cancer by hydrogel depot of paclitaxel nanocrystals. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 27238443 DOI: 10.1016/J.Jconrel.2016.05.056 |
0.346 |
|
| 2015 |
Park J, Park J, Pei Y, Xu J, Yeo Y. Pharmacokinetics and biodistribution of recently-developed siRNA nanomedicines. Advanced Drug Delivery Reviews. PMID 26686832 DOI: 10.1016/J.Addr.2015.12.004 |
0.356 |
|
| 2015 |
Pei Y, Yeo Y. Drug delivery to macrophages: Challenges and opportunities. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 26686082 DOI: 10.1016/J.Jconrel.2015.12.014 |
0.42 |
|
| 2015 |
Abouelmagd SA, Ku YJ, Yeo Y. Low molecular weight chitosan-coated polymeric nanoparticles for sustained and pH-sensitive delivery of paclitaxel. Journal of Drug Targeting. 23: 725-35. PMID 26453168 DOI: 10.3109/1061186X.2015.1054829 |
0.461 |
|
| 2015 |
Yeo Y, Jung JW, Park K, Kim ID. Graphene-Wrapped Anatase TiO2 Nanofibers as High-Rate and Long-Cycle-Life Anode Material for Sodium Ion Batteries. Scientific Reports. 5: 13862. PMID 26355340 DOI: 10.1038/srep13862 |
0.334 |
|
| 2015 |
Yeo Y, Kim BK. Drug Carriers: Not an Innocent Delivery Man. The Aaps Journal. PMID 26017163 DOI: 10.1208/S12248-015-9789-6 |
0.412 |
|
| 2015 |
Lee JH, Yeo Y. Controlled Drug Release from Pharmaceutical Nanocarriers. Chemical Engineering Science. 125: 75-84. PMID 25684779 DOI: 10.1016/J.Ces.2014.08.046 |
0.419 |
|
| 2015 |
Abouelmagd SA, Sun B, Chang AC, Ku YJ, Yeo Y. Release kinetics study of poorly water-soluble drugs from nanoparticles: are we doing it right? Molecular Pharmaceutics. 12: 997-1003. PMID 25658769 DOI: 10.1021/Mp500817H |
0.477 |
|
| 2015 |
Cho EJ, Sun B, Doh KO, Wilson EM, Torregrosa-Allen S, Elzey BD, Yeo Y. Intraperitoneal delivery of platinum with in-situ crosslinkable hyaluronic acid gel for local therapy of ovarian cancer. Biomaterials. 37: 312-9. PMID 25453960 DOI: 10.1016/J.Biomaterials.2014.10.039 |
0.482 |
|
| 2015 |
Park CG, Shasteen C, Amoozgar Z, Park J, Kim SN, Lee JE, Lee MJ, Suh Y, Seok HK, Yeo Y, Choy YB. Photo-crosslinkable chitosan hydrogel as a bioadhesive for esophageal stents Macromolecular Research. DOI: 10.1007/S13233-015-3115-0 |
0.626 |
|
| 2014 |
Feng M, Ibrahim BM, Wilson EM, Doh KO, Bergman BK, Park C, Yeo Y. Stabilization of a hyaluronate-associated gene delivery system using calcium ions. Biomaterials Science. 2: 936-942. PMID 25893092 DOI: 10.1039/C4Bm00012A |
0.691 |
|
| 2014 |
Abouelmagd SA, Hyun H, Yeo Y. Extracellularly activatable nanocarriers for drug delivery to tumors. Expert Opinion On Drug Delivery. 11: 1601-18. PMID 24950343 DOI: 10.1517/17425247.2014.930434 |
0.505 |
|
| 2014 |
Park J, Brust TF, Lee HJ, Lee SC, Watts VJ, Yeo Y. Polydopamine-based simple and versatile surface modification of polymeric nano drug carriers. Acs Nano. 8: 3347-56. PMID 24628245 DOI: 10.1021/Nn405809C |
0.441 |
|
| 2014 |
Liu KC, Yeo Y. Extracellular stability of nanoparticulate drug carriers. Archives of Pharmacal Research. 37: 16-23. PMID 24214175 DOI: 10.1007/S12272-013-0286-0 |
0.473 |
|
| 2013 |
Amoozgar Z, Park J, Lin Q, Weidle JH, Yeo Y. Development of quinic acid-conjugated nanoparticles as a drug carrier to solid tumors. Biomacromolecules. 14: 2389-95. PMID 23738975 DOI: 10.1021/Bm400512G |
0.734 |
|
| 2013 |
Gullotti E, Park J, Yeo Y. Polydopamine-based surface modification for the development of peritumorally activatable nanoparticles. Pharmaceutical Research. 30: 1956-67. PMID 23609560 DOI: 10.1007/S11095-013-1039-Y |
0.771 |
|
| 2013 |
Liu KC, Yeo Y. Zwitterionic chitosan-polyamidoamine dendrimer complex nanoparticles as a pH-sensitive drug carrier. Molecular Pharmaceutics. 10: 1695-704. PMID 23510114 DOI: 10.1021/Mp300522P |
0.397 |
|
| 2013 |
Cho EJ, Holback H, Liu KC, Abouelmagd SA, Park J, Yeo Y. Nanoparticle characterization: state of the art, challenges, and emerging technologies. Molecular Pharmaceutics. 10: 2093-110. PMID 23461379 DOI: 10.1021/Mp300697H |
0.742 |
|
| 2012 |
Sun B, Yeo Y. Nanocrystals for the parenteral delivery of poorly water-soluble drugs. Current Opinion in Solid State & Materials Science. 16: 295-301. PMID 23645994 DOI: 10.1016/J.Cossms.2012.10.004 |
0.373 |
|
| 2012 |
Doh KO, Yeo Y. Application of polysaccharides for surface modification of nanomedicines. Therapeutic Delivery. 3: 1447-56. PMID 23323561 DOI: 10.4155/Tde.12.105 |
0.354 |
|
| 2012 |
Gullotti E, Yeo Y. Beyond the imaging: Limitations of cellular uptake study in the evaluation of nanoparticles Journal of Controlled Release. 164: 170-176. PMID 22568932 DOI: 10.1016/J.Jconrel.2012.04.042 |
0.79 |
|
| 2012 |
Amoozgar Z, Park J, Lin Q, Yeo Y. Low molecular-weight chitosan as a pH-sensitive stealth coating for tumor-specific drug delivery. Molecular Pharmaceutics. 9: 1262-70. PMID 22489704 DOI: 10.1021/Mp2005615 |
0.713 |
|
| 2012 |
Amoozgar Z, Rickett T, Park J, Tuchek C, Shi R, Yeo Y. Semi-interpenetrating network of polyethylene glycol and photocrosslinkable chitosan as an in-situ-forming nerve adhesive. Acta Biomaterialia. 8: 1849-58. PMID 22310507 DOI: 10.1016/J.Actbio.2012.01.022 |
0.647 |
|
| 2012 |
Amoozgar Z, Yeo Y. Recent advances in stealth coating of nanoparticle drug delivery systems. Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology. 4: 219-33. PMID 22231928 DOI: 10.1002/Wnan.1157 |
0.747 |
|
| 2012 |
Bajaj G, Kim MR, Mohammed SI, Yeo Y. Hyaluronic acid-based hydrogel for regional delivery of paclitaxel to intraperitoneal tumors. Journal of Controlled Release : Official Journal of the Controlled Release Society. 158: 386-92. PMID 22178261 DOI: 10.1016/J.Jconrel.2011.12.001 |
0.43 |
|
| 2012 |
Bajaj G, Yeo Y. Erratum to “Hyaluronic acid-based hydrogel for regional delivery of paclitaxel to intraperitoneal tumors” [Journal of Controlled Release 158 (2012) 386–392] Journal of Controlled Release. 162: 257. DOI: 10.1016/J.Jconrel.2012.05.012 |
0.343 |
|
| 2012 |
Jee J, Na JH, Lee S, Kim SH, Choi K, Yeo Y, Kwon IC. Cancer targeting strategies in nanomedicine: Design and application of chitosan nanoparticles Current Opinion in Solid State and Materials Science. 16: 333-342. DOI: 10.1016/J.Cossms.2013.01.002 |
0.465 |
|
| 2011 |
Ibrahim BM, Park S, Han B, Yeo Y. A strategy to deliver genes to cystic fibrosis lungs: a battle with environment. Journal of Controlled Release : Official Journal of the Controlled Release Society. 155: 289-95. PMID 21843562 DOI: 10.1016/J.Jconrel.2011.07.039 |
0.711 |
|
| 2011 |
Yang Y, Tsifansky MD, Shin S, Lin Q, Yeo Y. Mannitol-guided delivery of Ciprofloxacin in artificial cystic fibrosis mucus model. Biotechnology and Bioengineering. 108: 1441-9. PMID 21488050 DOI: 10.1002/Bit.23046 |
0.418 |
|
| 2011 |
Ibrahim BM, Tsifansky MD, Yang Y, Yeo Y. Challenges and advances in the development of inhalable drug formulations for cystic fibrosis lung disease. Expert Opinion On Drug Delivery. 8: 451-66. PMID 21375469 DOI: 10.1517/17425247.2011.561310 |
0.735 |
|
| 2011 |
Holback H, Yeo Y. Intratumoral drug delivery with nanoparticulate carriers Pharmaceutical Research. 28: 1819-1830. PMID 21213021 DOI: 10.1007/S11095-010-0360-Y |
0.764 |
|
| 2011 |
Rickett TA, Amoozgar Z, Tuchek CA, Park J, Yeo Y, Shi R. Rapidly photo-cross-linkable chitosan hydrogel for peripheral neurosurgeries. Biomacromolecules. 12: 57-65. PMID 21128673 DOI: 10.1021/Bm101004R |
0.653 |
|
| 2010 |
Yeo Y. Battling with environments: Drug delivery to target tissues with particles and functional biomaterials Therapeutic Delivery. 1: 757-761. PMID 21339855 DOI: 10.4155/Tde.10.80 |
0.452 |
|
| 2010 |
Xu P, Bajaj G, Shugg T, Van Alstine WG, Yeo Y. Zwitterionic chitosan derivatives for pH-sensitive stealth coating. Biomacromolecules. 11: 2352-8. PMID 20695636 DOI: 10.1021/Bm100481R |
0.311 |
|
| 2010 |
Rask F, Dallabrida SM, Ismail NS, Amoozgar Z, Yeo Y, Rupnick MA, Radisic M. Photocrosslinkable chitosan modified with angiopoietin-1 peptide, QHREDGS, promotes survival of neonatal rat heart cells. Journal of Biomedical Materials Research. Part A. 95: 105-17. PMID 20540095 DOI: 10.1002/Jbm.A.32808 |
0.649 |
|
| 2010 |
Bajaj G, Yeo Y. Drug delivery systems for intraperitoneal therapy. Pharmaceutical Research. 27: 735-8. PMID 20198409 DOI: 10.1007/S11095-009-0031-Z |
0.446 |
|
| 2010 |
Ibrahim BM, Jun SW, Lee MY, Kang SH, Yeo Y. Development of inhalable dry powder formulation of basic fibroblast growth factor. International Journal of Pharmaceutics. 385: 66-72. PMID 19853028 DOI: 10.1016/J.Ijpharm.2009.10.029 |
0.688 |
|
| 2009 |
Yeo Y, Xu P. Nanoparticles for tumor-specific intracellular drug delivery. Conference Proceedings : ... Annual International Conference of the Ieee Engineering in Medicine and Biology Society. Ieee Engineering in Medicine and Biology Society. Annual Conference. 2009: 2403-5. PMID 19964955 DOI: 10.1109/IEMBS.2009.5334835 |
0.422 |
|
| 2009 |
Xu P, Quick GK, Yeo Y. Gene delivery through the use of a hyaluronate-associated intracellularly degradable crosslinked polyethyleneimine. Biomaterials. 30: 5834-43. PMID 19631979 DOI: 10.1016/J.Biomaterials.2009.07.012 |
0.316 |
|
| 2009 |
Gullotti E, Yeo Y. Extracellularly activated nanocarriers: A new paradigm of tumor targeted drug delivery Molecular Pharmaceutics. 6: 1041-1051. PMID 19366234 DOI: 10.1021/Mp900090Z |
0.762 |
|
| 2009 |
Yang Y, Bajaj N, Xu P, Ohn K, Tsifansky MD, Yeo Y. Development of highly porous large PLGA microparticles for pulmonary drug delivery. Biomaterials. 30: 1947-53. PMID 19135245 DOI: 10.1016/J.Biomaterials.2008.12.044 |
0.395 |
|
| 2009 |
Xu P, Gullotti E, Tong L, Highley CB, Errabelli DR, Hasan T, Cheng JX, Kohane DS, Yeo Y. Intracellular drug delivery by poly(lactic-co-glycolic acid) nanoparticles, revisited. Molecular Pharmaceutics. 6: 190-201. PMID 19035785 DOI: 10.1021/Mp800137Z |
0.796 |
|
| 2009 |
Rickett T, Amoozgar Z, Sun W, Yeo Y, Shi R. A photo-crosslinkable chitosan hydrogel for peripheral nerve anastomosis Proceedings of the 2009 2nd International Conference On Biomedical Engineering and Informatics, Bmei 2009. DOI: 10.1109/BMEI.2009.5305460 |
0.613 |
|
| 2008 |
Domnina YA, Yeo Y, Tse JY, Bellas E, Kohane DS. Spray-dried lipid-hyaluronan-polymethacrylate microparticles for drug delivery in the peritoneum. Journal of Biomedical Materials Research. Part A. 87: 825-31. PMID 18257078 DOI: 10.1002/Jbm.A.31741 |
0.37 |
|
| 2008 |
Snider C, Lee SY, Yeo Y, Grégori GJ, Robinson JP, Park K. Microenvironment-controlled encapsulation (MiCE) process: effects of PLGA concentration, flow rate, and collection method on microcapsule size and morphology. Pharmaceutical Research. 25: 5-15. PMID 17914663 DOI: 10.1007/S11095-007-9456-4 |
0.757 |
|
| 2008 |
Yeo Y, Kohane DS. Polymers in the prevention of peritoneal adhesions. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft FüR Pharmazeutische Verfahrenstechnik E.V. 68: 57-66. PMID 17881201 DOI: 10.1016/J.Ejpb.2007.03.027 |
0.366 |
|
| 2007 |
Yeo Y, Adil M, Bellas E, Astashkina A, Chaudhary N, Kohane DS. Prevention of peritoneal adhesions with an in situ cross-linkable hyaluronan hydrogel delivering budesonide. Journal of Controlled Release : Official Journal of the Controlled Release Society. 120: 178-85. PMID 17582645 DOI: 10.1016/J.Jconrel.2007.04.016 |
0.309 |
|
| 2007 |
Ito T, Yeo Y, Highley CB, Bellas E, Kohane DS. Dextran-based in situ cross-linked injectable hydrogels to prevent peritoneal adhesions. Biomaterials. 28: 3418-26. PMID 17470376 DOI: 10.1016/J.Biomaterials.2007.04.017 |
0.303 |
|
| 2007 |
Yeo Y, Ito T, Bellas E, Highley CB, Marini R, Kohane DS. In situ cross-linkable hyaluronan hydrogels containing polymeric nanoparticles for preventing postsurgical adhesions. Annals of Surgery. 245: 819-24. PMID 17457177 DOI: 10.1097/01.Sla.0000251519.49405.55 |
0.468 |
|
| 2007 |
Ito T, Yeo Y, Highley CB, Bellas E, Benitez CA, Kohane DS. The prevention of peritoneal adhesions by in situ cross-linking hydrogels of hyaluronic acid and cellulose derivatives. Biomaterials. 28: 975-83. PMID 17109954 DOI: 10.1016/J.Biomaterials.2006.10.021 |
0.309 |
|
| 2007 |
Yeo Y, Geng W, Ito T, Kohane DS, Burdick JA, Radisic M. Photocrosslinkable hydrogel for myocyte cell culture and injection. Journal of Biomedical Materials Research. Part B, Applied Biomaterials. 81: 312-22. PMID 16969828 DOI: 10.1002/Jbm.B.30667 |
0.34 |
|
| 2006 |
Jia X, Yeo Y, Clifton RJ, Jiao T, Kohane DS, Kobler JB, Zeitels SM, Langer R. Hyaluronic acid-based microgels and microgel networks for vocal fold regeneration. Biomacromolecules. 7: 3336-44. PMID 17154461 DOI: 10.1021/Bm0604956 |
0.305 |
|
| 2006 |
Fukuda J, Khademhosseini A, Yeo Y, Yang X, Yeh J, Eng G, Blumling J, Wang CF, Kohane DS, Langer R. Micromolding of photocrosslinkable chitosan hydrogel for spheroid microarray and co-cultures. Biomaterials. 27: 5259-67. PMID 16814859 DOI: 10.1016/J.Biomaterials.2006.05.044 |
0.307 |
|
| 2006 |
Yeo Y, Highley CB, Bellas E, Ito T, Marini R, Langer R, Kohane DS. In situ cross-linkable hyaluronic acid hydrogels prevent post-operative abdominal adhesions in a rabbit model. Biomaterials. 27: 4698-705. PMID 16750564 DOI: 10.1016/J.Biomaterials.2006.04.043 |
0.302 |
|
| 2006 |
Yeo Y, Burdick JA, Highley CB, Marini R, Langer R, Kohane DS. Peritoneal application of chitosan and UV-cross-linkable chitosan. Journal of Biomedical Materials Research. Part A. 78: 668-75. PMID 16739173 DOI: 10.1002/Jbm.A.30740 |
0.339 |
|
| 2006 |
Park JH, Ye M, Yeo Y, Lee WK, Paul C, Park K. Reservoir-type microcapsules prepared by the solvent exchange method: effect of formulation parameters on microencapsulation of lysozyme. Molecular Pharmaceutics. 3: 135-43. PMID 16579642 DOI: 10.1021/Mp050083W |
0.512 |
|
| 2006 |
Kohane DS, Tse JY, Yeo Y, Padera R, Shubina M, Langer R. Biodegradable polymeric microspheres and nanospheres for drug delivery in the peritoneum. Journal of Biomedical Materials Research. Part A. 77: 351-61. PMID 16425240 DOI: 10.1002/Jbm.A.30654 |
0.465 |
|
| 2004 |
Yeo Y, Park K. Characterization of reservoir-type microcapsules made by the solvent exchange method. Aaps Pharmscitech. 5: e52. PMID 15760049 DOI: 10.1208/Pt050452 |
0.489 |
|
| 2004 |
Yeo Y, Park K. A new microencapsulation method using an ultrasonic atomizer based on interfacial solvent exchange. Journal of Controlled Release : Official Journal of the Controlled Release Society. 100: 379-88. PMID 15567503 DOI: 10.1016/J.Jconrel.2004.09.012 |
0.437 |
|
| 2004 |
Yeo Y, Chen AU, Basaran OA, Park K. Solvent exchange method: a novel microencapsulation technique using dual microdispensers. Pharmaceutical Research. 21: 1419-27. PMID 15359577 DOI: 10.1023/B:Pham.0000036916.96307.D8 |
0.451 |
|
| 2004 |
Yeo Y, Park K. Control of encapsulation efficiency and initial burst in polymeric microparticle systems. Archives of Pharmacal Research. 27: 1-12. PMID 14969330 DOI: 10.1007/Bf02980037 |
0.513 |
|
| 2003 |
Yeo Y, Basaran OA, Park K. A new process for making reservoir-type microcapsules using ink-jet technology and interfacial phase separation. Journal of Controlled Release : Official Journal of the Controlled Release Society. 93: 161-73. PMID 14636722 DOI: 10.1016/J.Jconrel.2003.08.021 |
0.451 |
|
| 2001 |
Yeo Y, Baek N, Park K. Microencapsulation methods for delivery of protein drugs Biotechnology and Bioprocess Engineering. 6: 213-230. DOI: 10.1007/Bf02931982 |
0.535 |
|
| Show low-probability matches. |